Join us:
January 10–12, 2022 in-person in San FranciscoJanuary 17–19, 2022 virtually

Peter Marks
Director of Center for Biologics Evaluation and Research at U.S. Food and Drug Administration

Profile

Dr. Peter Marks is Director of the Center for Biologics Evaluation and Research (CBER) at FDA. He received his graduate and medical degrees from New York University. Following this, he completed an Internal Medicine residency and Hematology/Medical Oncology fellowship at Brigham and Women’s Hospital in Boston, where he subsequently joined the attending staff as a clinician-scientist and eventually served as Clinical Director of Hematology. He then moved on to work for several years in the pharmaceutical industry prior to returning to academic medicine at Yale University where he served as Chief Clinical Officer of Smilow Cancer Hospital. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

Agenda Sessions

  • Leveraging platform approaches to gene therapies to accelerate therapeutic development for monogenic diseases

    On Demand

Speakers at this event